XTX Topco Ltd

Position in SVRA — Savara Inc

CIK 1828301 LONDON, X0

Position in SVRA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,071,534

+$1,922,714 QoQ

Shares Held

379,402

+1437.3% QoQ

Ownership

0.185%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#54

of 184 holders

Holding Since

Jun 2021

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

XTX Topco Ltd holds $285,821,171 across 374 Biotechnology names. SVRA ranks #36 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	255,431	$7,075,438
2	VRTX	Vertex Pharmaceuticals Inc / Ma	15,632	$6,980,313
3	IONS	Ionis Pharmaceuticals Inc	80,519	$6,046,171
4	EXEL	Exelixis, Inc.	134,413	$5,764,973
5	NUVL	Nuvalent, Inc.	53,354	$5,466,117
6	AGIO	Agios Pharmaceuticals, Inc.	160,880	$5,442,570
7	BMRN	Biomarin Pharmaceutical Inc	93,609	$5,287,972
8	RYTM	Rhythm Pharmaceuticals, Inc.	59,502	$5,174,888

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,071,534	379,402	+1437.3%	Shares	Defined	2026-05-15
2025-12-31	$148,820	24,680	-36.2%	Shares	Defined	2026-02-17
2025-09-30	$138,041	38,667	-56.1%	Shares	Defined	2025-11-14
2025-06-30	$200,861	88,097	+691.1%	Shares	Defined	2025-08-12
2024-12-31	$34,187	11,136	-72.9%	Shares	Defined	2025-02-13
2024-06-30	$165,467	41,059	+289.1%	Shares	Defined	2024-08-12
2024-03-31	$52,543	10,551	-16.8%	Shares	Defined	2024-05-13
2023-06-30	$40,496	12,675	-35.2%	Shares	Defined	2023-08-14
2021-12-31	$24,258	19,563	-17.5%	Shares	Defined	2022-02-11
2021-09-30	$32,717	23,708	-64.4%	Shares	Defined	2021-11-12
2021-06-30	$113,133	66,549	—	Shares	Defined	2021-08-12
No filing history on record for this holder in this stock.